App-Based diets show promise for IBS relief
NCT ID NCT07607132
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested whether a digital platform offering two carbohydrate-reduced diets (low FODMAP or low-carb) could help adults with irritable bowel syndrome (IBS). 32 participants used the app for four weeks, reporting their symptoms and quality of life. The goal was to see if this digital approach is effective and practical for symptom relief.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
digital dietary platform with low FODMAP or low-carbohydrate diet
What this could lead to
If successful, this could provide a convenient, scalable way for people with IBS to manage their symptoms through diet without needing a dietitian.
What could go wrong
This is a small pilot study with only 32 participants and no control group, so results may not be reliable or apply to everyone. The diets may not work for all IBS patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dept of Internal Medicine, Sahlgrenska University Hospital
Gothenburg, 41345, Sweden